Billionaire Profile
Satish Reddy
Global Rank
#2667

Image: Unsplash Contributor | Unsplash License | via Unsplash

Satish Reddy

CEO, Pharmaceuticals
INDIA
Real-Time Net Worth
$1.484B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
-0.26% (24h)
Age
58
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
INDIA

Biography

Satish Reddy is the Chairman of Dr. Reddy's Laboratories, a leading Indian pharmaceutical company. With a net worth estimated at $1.6 billion, he is a prominent figure in the healthcare industry. His career began in 1993, leading the company's transformation into a diverse portfolio of finished dosage formulations. Reddy's achievements include expanding Dr. Reddy's global presence and actively participating in industry-shaping policies. He is also involved in philanthropy through the Dr. Reddy's Foundation.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Kallam Satish Reddy was born on June 9, 1967, in Hyderabad, India. He is the son of K. Anji Reddy, the founder of Dr. Reddy's Laboratories. His father, a pioneer in the Indian pharmaceutical sector, established the company in 1984 after working in public-sector drug research. Satish completed his Bachelor of Science in Chemical Engineering from Osmania University in 1988 and later earned a Master of Science in Medicinal Chemistry from Purdue University.

Rise to Success

Satish Reddy joined Dr. Reddy's Laboratories in 1993 as an executive director. He rose through the ranks, becoming the Managing Director in 1997. Under his leadership, the company transitioned from a manufacturer of active pharmaceutical ingredients to one with a diverse product portfolio of finished dosage formulations. He was instrumental in establishing a strong footprint for Dr. Reddy's finished dosage products in Russia, CIS countries, and other emerging markets. He was named Chairman in May 2014.

Key Business Strategies

Satish Reddy has been pivotal in shaping the strategies of Dr. Reddy's Laboratories. Key strategies have included expanding the product portfolio, focusing on finished dosage formulations, and increasing the company's global reach, particularly in North America and emerging markets. He also spearheaded the launch of innovative products like Nerivio, a wearable therapy device for migraines, in December 2023. Additionally, he has been actively involved in shaping policies related to the pharmaceutical sector and the economy.

Philanthropy

Beyond his corporate role, Satish Reddy is actively involved in philanthropic endeavors. He serves as the Chairman of the Dr. Reddy's Foundation, which focuses on helping the less privileged create sustainable livelihoods through vocational education. He is also a Trustee of the Naandi Foundation, which works in areas related to child rights, education, safe drinking water, and other empowerment initiatives.

Career Milestones

1993

Executive Director

Joined Dr. Reddy's Laboratories as Executive Director.

1997

Managing Director

Elevated to Managing Director, leading the company's transformation.

2007

Young Global Leader

Recognized by the World Economic Forum.

2014

Chairman

Appointed as Chairman of Dr. Reddy's Laboratories.

2023

Nerivio Launch

Launched the wearable therapy device Nerivio to treat migraines.

Philanthropy & Social Impact

Vocational Education

Dr. Reddy's Foundation

Undisclosed

Works to help the less privileged create sustainable livelihoods through vocational education.

Child Rights and Education

Naandi Foundation

Undisclosed

Focuses on child rights, education, and safe drinking water initiatives.